Literature DB >> 7912488

Somatostatin and the treatment of pancreatic cancer.

G J Poston1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912488      PMCID: PMC2502308     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  16 in total

Review 1.  Oncological applications of somatostatin analogues.

Authors:  A V Schally
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

2.  Hormonal control of pancreatic cancer growth.

Authors:  C Liebow; M Hierowski; K duSapin
Journal:  Pancreas       Date:  1986       Impact factor: 3.327

3.  Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice.

Authors:  G J Poston; C M Townsend; S Rajaraman; J C Thompson; P Singh
Journal:  Pancreas       Date:  1990-03       Impact factor: 3.327

4.  Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.

Authors:  B Szende; A Zalatnai; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.

Authors:  C Liebow; C Reilly; M Serrano; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.

Authors:  A Zalatnai; A V Schally
Journal:  Int J Pancreatol       Date:  1989-03

7.  Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line.

Authors:  M T Hierowski; C Liebow; K du Sapin; A V Schally
Journal:  FEBS Lett       Date:  1985-01-07       Impact factor: 4.124

9.  Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

Authors:  J R Upp; D Olson; G J Poston; R W Alexander; C M Townsend; J C Thompson
Journal:  Am J Surg       Date:  1988-01       Impact factor: 2.565

10.  Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression.

Authors:  B Szende; G Srkalovic; A V Schally; K Lapis; K Groot
Journal:  Cancer       Date:  1990-05-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.